With IGE falling as it has, I am surprised this has not dropped back to 3/3.5p
Maybe it is just delayed reaction. |
Upped my holding to 80,000 shares. Budget didnt have any really bad shocks so happy to go forward. £3000 not a lot to risk on this one. |
my thoughts at first, but having spent last hour looking at paperwork for IQAI for last two years it looks to be on an even keel with a good upside. As with a lot of this companies investments they are at the bottom of the food chain and most wouldnt get involved for a possible couple of hundred thousand pound upside. But most of the companies like this have a high probability of making money at some point.
I will add that they now seem to have spent most of the money they had in the bank and going forward I would like to see a positive bank balance again at some point. |
It seems to me clever Trevor is off loading a dud he and is family own on to BRH. |
Ok I realised I forgot the cash held, as the priced dropped today I bought a few at 4p so that I can keep an eye on them. |
Death spiral here I think. |
Latest contract for UK defense, for x ray machines. |
Good ti sse braveheart hilding 7.21% from 5.21% in Image Scan Holdings, Holdings over 9 million for braveheart. Image Scan business progressing rapidly. |
https://www.organonachip.org.uk/people/bhumika-singhhttps://www.qmul.ac.uk/media/news/2020/se/queen-mary-opens-organs-on-chips-centre-for-advancements-in-medical-research-and-drug-development.html |
Organ on a chip is going to be huge, research and development already way ahead in china's facilities and universities. |
serving as the central processing unit (CPU) of the intelligent entity, is the core of achieving intelligent capabilities on the chip, aiming to efficiently simulate and analyze the brain. The brain-like organ, which, despite having a structure and function similar to tserving as the central processing unit (CPU) of the intelligent entity, is the core of achieving intelligent capabilities on the chip, aiming to efficiently simulate and analyze the brain. The brain-like organ, which, despite having a structure and function similar to the human brain, still faces challenges such as low maturity and inadequate nutrient supply, according to the Tianjin University research team.he human brain, still faces challenges such as low maturity and inadequate nutrient supply, according to the Tianjin University research team. |
https://www.globaltimes.cn/page/202406/1314882.shtml |
https://www.cambridgenetwork.co.uk/news/cn-bio-appoints-lydia-seymour-vp-people-and-culture-further-strengthen-leadership-team |
https://www.qmul.ac.uk/media/news/2024/se/queen-mary-university-of-london-leads-17-million-project-to-revolutionise-drug-discovery-with-next-generation-organ-chip-technology.html |
Covid paused this for a long time, now it should go to where it was during that period now that they have a distributor for one of their holdings, and patent pending for the other. |
Paraytec has also developed technical notes on how the CX300 can be used for the detection of protein aggregation, an important factor for protein producers and users, and adeno-associated virus which are used in gene therapy."Three universities have signed sales contracts, two for use in their work on extracellular vesicles, with others showing interest in that area." |
https://www.proactiveinvestors.co.uk/companies/news/1052561/braveheart-investee-kirkstall-secures-chinese-distributor-for-quasi-vivo-1052561.html |
Trevor likes to sell into strength before awarding himself more shares |
Pump before the fundraise? |
take profit and run! |
Excellent progress about time, all that covid delays. |
Haven't looked at these too closely, but I can't see any reason to buy in. It all seems to rest on the performance of Autins and I can't see much to get excited about there. |
Those right offs of the two main companies make things look bad but they could both come roaring back. Development has not stopped. |
Register for streaming realtime charts, analysis tools, and prices.
Hot Features
Premium
